The store will not work correctly when cookies are disabled.
3,6-dichloro-9-(4-(4-methylpiperazin-1-yl)butyl)-9H-carbazole
ID: ALA5268677
Max Phase: Preclinical
Molecular Formula: C21H25Cl2N3
Molecular Weight: 390.36
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(CCCCn2c3ccc(Cl)cc3c3cc(Cl)ccc32)CC1
Standard InChI: InChI=1S/C21H25Cl2N3/c1-24-10-12-25(13-11-24)8-2-3-9-26-20-6-4-16(22)14-18(20)19-15-17(23)5-7-21(19)26/h4-7,14-15H,2-3,8-13H2,1H3
Standard InChI Key: XEEWQXPSQVCRCB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
3.1160 -2.5511 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5444 -2.2211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5444 -1.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8299 -0.9836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1155 -1.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3312 -1.1412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1536 -1.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9735 -1.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3090 -2.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8240 -3.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0037 -3.2293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3312 -2.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1155 -2.2211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8299 -2.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0925 -3.9185 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.0751 -0.3579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7324 -0.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9889 0.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7966 0.7678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0526 1.5523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5012 2.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7572 2.9508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5646 3.1213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8600 1.7229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1160 2.5074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7782 3.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
12 13 1 0
13 5 2 0
13 14 1 0
14 2 2 0
10 15 1 0
6 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 21 1 0
23 22 1 0
24 20 1 0
25 24 1 0
25 23 1 0
23 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 390.36 | Molecular Weight (Monoisotopic): 389.1426 | AlogP: 5.13 | #Rotatable Bonds: 5 |
Polar Surface Area: 11.41 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.61 | CX LogP: 4.97 | CX LogD: 3.73 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.56 | Np Likeness Score: -1.12 |
References
1. Clausen JD, Kjellerup L, Cohrt KO, Hansen JB, Dalby-Brown W, Winther AL.. (2017) Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives., 27 (19): [PMID:28893470] [10.1016/j.bmcl.2017.08.067] |